Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/48216
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlter, Peter-
dc.contributor.authorWatz, Henrik-
dc.contributor.authorVILACA CAVALLARI MACHADO, Felipe-
dc.contributor.authorSpeicher, Tim-
dc.contributor.authorTrudzinski, Franziska C.-
dc.contributor.authorKahnert, Kathrin-
dc.contributor.authorBals, Robert-
dc.contributor.authorWouters , Emiel Fm-
dc.contributor.authorFranssen, Frits Me-
dc.contributor.authorVogelmeier, Claus F.-
dc.contributor.authorKarrasch, Stefan-
dc.contributor.authorJorres, Rudolf-
dc.date.accessioned2026-01-22T13:10:18Z-
dc.date.available2026-01-22T13:10:18Z-
dc.date.issued2025-
dc.date.submitted2026-01-09T13:39:47Z-
dc.identifier.citationInternational Journal of Chronic Obstructive Pulmonary Disease, 20 , p. 4129 -4141-
dc.identifier.urihttp://hdl.handle.net/1942/48216-
dc.description.abstractBackground: Body weight plays an intricate role in COPD, as obesity can impair lung function and thus might affect COPD categorization. We asked to which extent overweight/obesity affects conventional COPD scores taking into account lung function and potential restrictive patterns (PRISm, preserved ratio and impaired spirometry). Methods: Patients of the COSYCONET cohort were included. Outcomes were the modified Medical Research Council (mMRC) questionnaire, the COPD Assessment Test (CAT), CAT question #4 (dyspnea upon exertion), the St George's Respiratory Questionnaire (SGRQ) and its domains, and the EQ-5D-VAS (EuroQoL-5-dimension) questionnaire for generic quality of life. Body mass index (BMI) was categorized into <25, >= 25 to <30, and >= 30 kg/m2. The relationship between outcomes and predictors including airway obstruction, lung hyperinflation, air trapping and CO diffusing capacity was assessed by generalized linear models in a repeated measures design. Results: Data from visits 1, 3, 4 and 5 were available in n=2478, 1855, 1291 and 944 patients, respectively, of whom 169, 132, 95 and 63 fulfilled the PRISm criterion. For mMRC, CAT total, CAT dyspnoea (#4), EQ-5D-VAS, SGRQ total, Activity and Impact, scores were higher in the upper two BMI categories compared to the lower one (p<0.05 each), without further significant dependence on PRISm or an interaction between BMI and PRISm. For SGRQ Symptoms, only the upper BMI category showed a significantly higher score. All scores depended (p<0.05 each) on lung function and exacerbation history in terms of GOLD group E. Conclusion: For common indicators of the burden from COPD, BMI played a significant role by increasing these scores even if confounders were taken into account. Compared to the lowest BMI category, there was a continuous increase with overweight and obesity. Categorization into PRISm did not influence the relationship between BMI and symptom scores. The underlying mechanisms probably involve mechanical but also systemic factors. Based on this, COPD categorizations based on the scores studied probably should consider the effects of BMI.-
dc.description.sponsorshipFunding COSYCONET is supported by the German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET) and performed in collaboration with the German Center for Lung Research (DZL). The project is funded by the BMBF with grant number 01 GI 0881, and by DZL with grant-number 82DZLI05B2. It is furthermore supported by unrestricted grants from AstraZeneca GmbH, Bayer Schering Pharma AG, Boehringer Ingelheim Pharma GmbH & Co. KG, Chiesi GmbH, GlaxoSmithKline, Grifols Deutschland GmbH, MSD Sharp & Dohme GmbH, Mundipharma GmbH, Novartis Deutschland GmbH, Pfizer Pharma GmbH, Sanofi-Aventis Deutschland GmbH, Takeda Pharma Vertrieb GmbH & Co. KG, Teva GmbH for patient investigations and laboratory measurements. The funding body had no involvement in the design of the study, or the collection, analysis or interpretation of the data. Acknowledgments We are grateful to all COSYCONET study centers, especially to all study nurses and physicians, for their excellent and enduring work in data collection, as well as to all patients who were willing to participate in this study over an extended period of time. The data management and quality assurance support provided by CAPNETZ STIFTUNG is gratefully acknowledged.-
dc.language.isoen-
dc.publisherDOVE MEDICAL PRESS LTD-
dc.rights2025 Alter et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.phpand incorporate the Creative Commons Attribution – Non Commercial (unported, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0/). By accessing the workyou hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Forpermission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).-
dc.subject.otherCOPD-
dc.subject.otherobesity-
dc.subject.otherlung function-
dc.subject.otherPRISm-
dc.subject.othersymptoms-
dc.subject.otherquality of life-
dc.titleAssociation of Obesity with Symptoms and Quality of Life in COPD: Results from COSYCONET-
dc.typeJournal Contribution-
dc.identifier.epage4141-
dc.identifier.spage4129-
dc.identifier.volume20-
local.format.pages13-
local.bibliographicCitation.jcatA1-
dc.description.notesAlter, P (corresponding author), Philipps Univ Marburg UMR, German Ctr Lung Res DZL, Dept Med Pulm Crit Care & Sleep Med, Baldingerstr 1, Marburg, Germany.-
dc.description.notesAlter@Uni-Marburg.de-
local.publisher.placePO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.2147/COPD.S542628-
dc.identifier.pmid41476636-
dc.identifier.isi001651446500001-
dc.identifier.eissn-
local.provider.typewosris-
local.description.affiliation[Alter, Peter; Speicher, Tim; Wouters, Emiel Fm; Franssen, Frits Me; Vogelmeier, Claus F.] Philipps Univ Marburg UMR, German Ctr Lung Res DZL, Dept Med Pulm Crit Care & Sleep Med, Baldingerstr 1, Marburg, Germany.-
local.description.affiliation[Watz, Henrik; Franssen, Frits Me] Veloc Clin Res Germany GmbH, Ahrensburg, Germany.-
local.description.affiliation[Machado, Felipe Vc; Karrasch, Stefan] Hasselt Univ, Fac Rehabil Sci, Rehabil Res Ctr REVAL, Diepenbeek, Belgium.-
local.description.affiliation[Machado, Felipe Vc] Hasselt Univ, Biomed Res Inst BIOMED, Fac Med & Life Sci, Diepenbeek, Belgium.-
local.description.affiliation[Trudzinski, Franziska C.] Thoraxklin Univ Heidelberg, Translat Lung Res Ctr Heidelberg TLRC H, German Ctr Lung Res DZL, Dept Pneumol & Crit Care Med, Heidelberg, Germany.-
local.description.affiliation[Kahnert, Kathrin] Ludwig Maximilians Univ Munchen, Univ Hosp, Comprehens Pneumol Ctr CPC M, Dept Internal Med 5,German Ctr Lung Res DZL, Munich, Germany.-
local.description.affiliation[Kahnert, Kathrin] MediCenterGermering, Germering, Germany.-
local.description.affiliation[Bals, Robert] Saarland Univ Hosp, Dept Internal Med Pulmonol 5, Allergol, Intens Care Med, Homburg, Germany.-
local.description.affiliation[Wouters, Emiel Fm] Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands.-
local.description.affiliation[Wouters, Emiel Fm] Sigmund Freud Private Univ, Med Fac, Vienna, Austria.-
local.description.affiliation[Franssen, Frits Me] Ciro, Dept Res & Dev, Horn, Netherlands.-
local.description.affiliation[Franssen, Frits Me] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Resp Med, Maastricht, Netherlands.-
local.description.affiliation[Karrasch, Stefan; Jorres, Rudolf] Ludwig Maximilians Univ Munchen, Inst & Outpatient Clin Occupat Social & Environm, Comprehens Pneumol Ctr Munich CPC M, German Ctr Lung Res DZL,Univ Hosp, Munich, Germany.-
local.uhasselt.internationalyes-
item.contributorAlter, Peter-
item.contributorWatz, Henrik-
item.contributorVILACA CAVALLARI MACHADO, Felipe-
item.contributorSpeicher, Tim-
item.contributorTrudzinski, Franziska C.-
item.contributorKahnert, Kathrin-
item.contributorBals, Robert-
item.contributorWouters , Emiel Fm-
item.contributorFranssen, Frits Me-
item.contributorVogelmeier, Claus F.-
item.contributorKarrasch, Stefan-
item.contributorJorres, Rudolf-
item.fullcitationAlter, Peter; Watz, Henrik; VILACA CAVALLARI MACHADO, Felipe; Speicher, Tim; Trudzinski, Franziska C.; Kahnert, Kathrin; Bals, Robert; Wouters , Emiel Fm; Franssen, Frits Me; Vogelmeier, Claus F.; Karrasch, Stefan & Jorres, Rudolf (2025) Association of Obesity with Symptoms and Quality of Life in COPD: Results from COSYCONET. In: International Journal of Chronic Obstructive Pulmonary Disease, 20 , p. 4129 -4141.-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
crisitem.journal.issn1178-2005-
crisitem.journal.eissn1178-2005-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Association of Obesity with Symptoms and Quality of Life in COPD Results from COSYCONET.pdfPublished version872.39 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.